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VIDEORichard F. Knoop, MD,1 Hans-Juergen Richter-Schrag, MD,1 Steffen Heeg, MD,1 Jens Hoeppner, MD,2
Andreas Fischer, MD1Figure 1. Upper endoscopic view before operation, showing a thickened,
contact-vulnerable, exophytic, and lumen-constricting verrucous mass in
the esophagus over a distance of 15 cm (asterisk Z esophageal lumen).
(From Kulemann B, Fischer A, Hoeppner J. Esophageal stenosis caused by
a rare entity. Gastroenterology 2014;146:618-871. Used with permission.)A 47-year-old man with stenosing verrucous carcinoma
of the mid and distal esophagus (Figs. 1 and 2)
underwent an abdominothoracic esophagectomy.1 The
resection was complicated by severely hardened
periesophageal inﬂammation tissue. Therefore, the
initially intended total esophagectomy with a collar
anastomosis was abandoned intraoperatively in favor of a
subtotal resection with an intrathoracic anastomosis
27 cm from the incisors.
Staging and grading showed G1pT2pN0(0/15)
L0V0Pn0R0 status (Figs. 3 and 4). At day 15, the patient
was discharged in good clinical condition after an
uneventful postoperative course.1 During the follow-up
period, an endoscopy initially showed a regular postopera-
tive result with normal esophageal mucosa and an unsug-
gestive anastomosis (Video 1, available online at www.
VideoGIE.org). However, 22 months after the operation,
another endoscopy revealed suggestive, disseminated,
white spot-like lesions affecting the entire remaining esoph-
ageal mucosa (Fig. 5 and Video 1, available online at www.
VideoGIE.org). As suspected, pathologic examination
conﬁrmed the recurrence of verrucous carcinoma in the
entire remaining esophagus. A penetration depth of up to
500 mm (pT1a) was determined on the basis of biopsy
specimens (taken by Jumbo Biopsy Forceps, Endo-Flex,
Voerde, Germany); the histologic evaluation was conducted
by a calibrated eyepiece.
Subsequently, the interdisciplinary consensus with
the attending surgeons was to attempt an interventional
endoscopic approach to postpone or even avoid a second
tumor resection. Given that the mucosa was affected only
superﬁcially (500 mm), radiofrequency ablation (RFA),
with a known penetration depth of 800 mm to 1000 mm,
seemed to be a promising option.2 Within an interval of
3 months, 2 consecutive RFA sessions (Fig. 6 and
Video 1, available online at www.VideoGIE.org) were
performed by use of the Barrx 90 and the Barrx 60 RFA
Focal Catheter (Covidien, Mansﬁeld, Mass). The standard
ablation regimen was chosen, 2 applications of energy
(15 J/cm2) were given, the ablation zone was cleaned, and
2 additional applications of energy were given according
to the Van Vilsteren simpliﬁed ablation method.3,4cript of the video audio is available online at www.VideoGIE.org.
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the remaining esophagus, the examination of which
demonstrated unsuggestive mucosa but a persisting small
recurrence of the verrucous carcinoma at the level of the
esophagogastrostomy (Fig. 7). Because of the very
localized extent of the latter, ablation with argon plasma
coagulation (MABS-GIT 2.3 mm, KLS Martin, Tuttlingen,
Germany), with maximum 30 W, ﬂow 0.6 L/min, was
conducted twice within an interval of 2 months. Further
control determinations still remained suggestive of
relapse of verrucous carcinoma limited to this site only
(Fig. 8).
The case was again discussed with the interdisciplinary
tumor board. Precise external radiation therapy was sug-
gested, with the aim of exclusively irradiating the area of
anastomosis to preserve an exit strategy for a second surgi-www.VideoGIE.org
Figure 2. CT scans with contrast enhancement showing long-segment thickening of the thoracic esophagus (arrows) without signs of lymphadenopathy
or metastases.
Figure 3. Surgical specimen with hyperkeratotic, exophytic growth of the
tumor (arrow) and normal esophageal tissue (asterisk). (From Kulemann
B, Fischer A, Hoeppner J. Esophageal stenosis caused by a rare entity.
Gastroenterology 2014;146:618-871. Used with permission.)
Figure 4. Microscopic view of verrucous esophageal carcinoma showing
invasive characteristics (arrow). (From Kulemann B, Fischer A, Hoeppner
J. Esophageal stenosis caused by a rare entity. Gastroenterology
2014;146:618-871. Used with permission.)
Knoop et al Video Case Reportcal resection in terms of a colonic interposition. In this
case, an esophagocolostomy could be performed as a
collar anastomosis in a nonirradiated proximal esophagus
remnant. For this purpose, EGD was used to mark the
area of anastomosis with a lipiodol injection for exact local-
ization in the radiation treatment planning. High-precision
radiation of this site was then performed over a period of
2 months with single doses of 1.8 Gy and a total dose of
55.8 Gy.
Since then, the remaining esophagus that was not irra-
diated, for the reasons mentioned, has remained free of
tumors for 18 months (Fig. 9 and Video 1, available
online at www.VideoGIE.org).BACKGROUND AND DISCUSSION
Verrucous carcinoma of the esophagus is very rare; only
approximately 25 cases have been reported worldwide.
Consequently, only limited data are available, and treat-www.VideoGIE.orgment approaches should be individualized in agreement
with the patient. The leading symptoms are odynophagia
and dysphagia followed by weight loss. As a result of the
histopathologic resemblance of this entity to that of esoph-
ageal squamous cell carcinoma, the diagnostic and thera-
peutic standards of the latter have been adopted.5 This
applies particularly to local endoscopic therapy.6
Although classiﬁed as a variant of squamous cellVolume 1, No. 4 : 2016 VIDEOGIE 79
Figure 5. Early disseminated recurrence of verrucous carcinoma in the
remaining esophagus 22 months after esophageal resection with intratho-
racic esophagogastrostomy.
Figure 6. Endoscopic radiofrequency ablation with use of a Barrx 90 RFA
Focal Catheter.
Figure 7. First local recurrence limited strictly to the anastomotic site 6
months after radiofrequency ablation (arrows).
Figure 8. Persistent local recurrence limited strictly to the anastomotic
site (arrows) after additional argon-plasma coagulation by use of a
MABS-GIT probe.
Figure 9. The main part of the initially affected esophagus has remained
free of tumor 18 months after radiofrequency ablation.
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Video Case Report Knoop et alcarcinoma, esophageal verrucous carcinomas bear several
speciﬁc characteristics. In particular, although locally
spreading, they usually do not lead to lymph node
involvement or distant metastasis and can therefore be
characterized as semimalignant.5,6 Furthermore, they
show a much lower response to chemoradiotherapy.6
Those are also the main reasons why initial neoadjuvant
therapy was not provided to our patient.
Endoscopic radiofrequency ablation is a well-validated
therapy for dysplastic Barrett’s disease, and it also has
become increasingly accepted for early squamous cell car-
cinoma of the esophagus.2,7,8
In our case, relapsing verrucous carcinoma involved the
whole circumference of the remaining esophagus. On that
account and because of an entire lack of lifting at the anas-
tomotic site, neither EMR nor endoscopic submucosal
dissection was considered feasible as a therapeutic option.www.VideoGIE.org
Knoop et al Video Case ReportRFA led to complete tumor remission except in the area of
anastomosis. The reasons for this might be that the pene-
tration depth was too deep (>800 mm) at the anastomotic
site or that the anastomotic tissue was too uneven for a
tight connection between the RFA catheter and the esoph-
ageal wall.
However, RFA was very effective except from the anas-
tomotic area because of the previously mentioned reasons.
In case of an early verrucous esophageal carcinoma
(<800-mm invasion depth) and good transmission of
thermal energy, RFA seems to be an effective treatment
option.CONCLUSIONS
To the best of our knowledge, this is the ﬁrst report
demonstrating the efﬁcacy of RFA in early-stage verrucous
esophageal carcinoma. Because of its slow and semimalig-
nant growth, RFA treatment appears to be acceptable to
prevent or at least postpone the need for surgery.
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